BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston

About this update from Biomarin Pharmaceutical Inc.

SAN RAFAEL, Calif. , Aug. 10, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced management will present at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston. An audio webcast of the presentation will be available live. The webcast can be accessed at: https://investors.biomarin.com/ . An archived version of the remarks will also be available through the Company's website for a limited time following the conference. About BioMarin BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit www.biomarin.com .  Contacts: Investors Media Traci McCarty Marni Kottle BioMarin Pharmaceutical Inc.           BioMarin Pharmaceutical Inc. (415) 455-7558 ( 650) 374-2803   View original content to download multimedia: https://www.prnewswire.com/news-releases/biomarin-to-participate-at-the-canaccord-genuity-46th-annual-growth-conference-on-wednesday-august-12-2026-at-800am-et-in-boston-302844104.html SOURCE BioMarin Pharmaceutical Inc.

View stock analysis, news, and events for Biomarin Pharmaceutical Inc.